Presentación
AIDS AND INFECTIUOS DISEASES GROUP

sidayenfermedadesinfecciosas@idipaz.es
Excellence Group
Composition
Name
Position
Institution
Jefe de Sección del Servicio de Medicina Interna (Unidad de Infecciosas)
Profesor Titular
Hospital Universitario La Paz
Universidad Autónoma de Madrid
Marta Arsuaga Vicente
Médico Adjunto en Medicina Interna
Hospital Carlos III- Hospital Universitario La Paz
José Ignacio Bernardino de la Serna
Facultativo Especialista de Área en Medicina Interna. Unidad VIH
Hospital Universitario La Paz
Carmen Busca Arenzana
Contrato Río Hortega
Hospital Universitario La Paz
Julen Cadiñanos Loidi
Contrato Río Hortega
Hospital Universitario La Paz
Fernando de la Calle Prieto
Médico adjunto en Medicina Interna. Unidad de Medicina Tropical
Profesor Colaborador
Hospital Carlos III - Hospital Universitario La Paz - Universidad Autónoma de Madrid
Rosa de Miguel Buckley
Facultativo Especialista Adjunto en Medicina Interna
Hospital Universitarios La Paz
Marta Díaz Menéndez
Médico adjunto en Medicina Interna.
Unidad de Medicina Tropical
Hospital Universitario La Paz
Beatriz Díaz Pollán
Facultativo Especialista de Área en Medicina Interna. Unidad de Enfermedades Infecciosas y Microbiología Clínica
Hospital Universitario La Paz
Alejandro Díez Vidal
Facultativo Especialista de Área en Medicina Interna
Hospital Universitario La Paz
Andrés Esteban Cantos
Predoctoral research
Hospital Universitario La Paz
Marta Gálvez Charro
Nurse. HIV unit 
Hospital Universitario La Paz
Nicolás García-Arenzana Les
Facultativo Especialista de Área en Medicina Preventiva
Hospital Universitario La Paz
Francisco Gayá Moreno
Investigador Predoctoral (Contrato de Estabilización de Técnicos de Apoyo)
Hospital Universitario La Paz
Juan Julián González García
Facultativo Especialista de Área en Medicina Interna. Unidad de VIH
Hospital Universitario La Paz
Lucía Gutierrez García
Predoctoral research  
FIBHULP
Pedro Herranz Pinto
Facultativo Especialista de Área en Dermatología. Jefe de Sección
Hospital Universitario La Paz
Víctor Hontañón Antoñana
Predoctoral research  
Hospital Universitario La Paz
María Jiménez González
Biostatistics
FIBHULP
María del Mar Lago Núñez
Facultativo Especialista de Área en Medicina Interna. Unidad de Medicina Tropical
Hospital Carlos III - Hospital Universitario La Paz
Cristina Marcelo Calvo
Contrato Rio Hortega
Hospital Universitario La Paz
Luz Martín Carbonero
Facultativo Especialista de Área
Hospital Universitario La Paz
Patricia Martínez Martín
Médico Adjunto en Medicina Interna
Hospital Universitario La Paz
Mario Mayoral Muñoz
Nurse
Hospital Universitario La Paz
Juan José Miguel Castro
Nurse
Hospital Universitario La Paz
Rocío Montejano Sánchez
Postdoctoral research
Hospital Universitario La Paz
María Luisa Montes Ramírez
Facultativo Especialista de Área de Medicina Interna. Unidad de VIH
Hospital Universitario La Paz
Marta Mora Rillo
Facultativo Especialista de Área de Medicina Interna. Unidad de Enfermedades Infecciosas y Microbiología Clínica
Hospital Universitario La Paz
Francisco Moreno Ramos
Pharmacist
Hospital Universitario La Paz
Carlos Manuel Oñoro López
Médico Interno Residente
FIBHULP
Juan Carlos Ramos Ramos
Facultativo Especialista de Área en Medicina Interna
Hospital Universitario La Paz
Luis Ramos Ruperez
Investigación Rio Hortega
Hospital Universitario La Paz
Berta Rodés Soldevila
Senior research
Hospital Universitario La Paz
Javier Rodríguez Centeno
Postdoctoral research 
Hospital Universitario o La Paz
Elena Sendagorta Cudós
Facultativo Especialista de Área de Dermatología
Hospital Universitario La Paz
Lucía Serrano Morago
Postdoctoral research 
Hospital Universitario La Paz
Eulalia Valencia Ortega
Facultativo Especialista de Área en Medicina Interna
Hospital Univeristario La Paz
Strategic Objetive
Although great progress has been made, HIV infection remains an incurable disease. Even under the best circumstances, HIV-infected patients who receive current antiretroviral therapy have a survival disadvantage compared with the general non-infected population, which is estimated to be a life expectancy of 15 years less than the general population.
HIV infection is highly prevalent in Spain. Among western European countries, Spain has the second highest prevalence. An important local characteristic of the HIV-infected population in Spain is the high prevalence of hepatitis C coinfection.
This research line covers four main topics of research in HIV infection: antiretroviral treatment, HIV-HCV coinfection, metabolic complications and HIV-resistance to antiretroviral drugs. In addition, we are planning to start another research project on infections other than HIV.
The group has started a new research line regarding the aging and HIV Infection.
Tropical diseases are increasing as a consequence of global travel. These diseases continue to be relatively rare however, and therefore, often sub-optimal treated if managed by non-speciaslists. Furthermore, every year an increasing amount of special travelers (pregnants, comorbidities, immunossupressed) travel abroad, adding complexity in terms of a timely and effective diagnosis and management. The Tropical and Travel Medicine Unit provide both pre and postravel assistance in imported infectious diseases. The aim of this Unit is to provide efficient and effecrive specialist care with proven or suspected tropical disease and a specific preventative travel advice, togheter with international vaccines recommended for the trip.
Research Lines
• Antiretroviral therapy & resistance.
• Metabolic complications of antiretroviral therapy.
• Liver disease.
• Neurocognitive impairment.
• Paediatric HIV infection and MTCT.
• Epigenetic and cellular factors related to HIV progression
• Optimisation of antibiotic therapy (ID no HIV)
• Tropical diseases
• Emerging and re-emerging virus